RxDoctor Payments Data

Jennifer Black, APRN

Nurse Practitioner · Ogden, UTNPI 1811671449

Payments from drug & device makers

$525in general payments, 2019–2025

Across 30 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$115
  • Johnson & Johnson$73
  • AstraZeneca$58
  • Astellas Pharma US Inc$46
  • Amgen$45
  • Idorsia Pharmaceuticals US Inc$34
  • plus $154 from 8 others

What the payments were for

  • Food & beverage$525100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$525 in reported general payments places this provider in the 70th percentile of 979 nurse practitioner providers in Utah.

See all nurse practitioner providers in Utah

Medicare billing

Part B allowed, 2024
$23,491
Medicare patients
122
Services billed
2,080

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol11$4,016
Gabapentin75$1,175
Methocarbamol41$900
Trazodone Hcl41$749
Albuterol Sulfate HfaAlbuterol Sulfate24$720
Duloxetine Hcl24$652
Omeprazole58$638
Atorvastatin Calcium70$606
Metformin Hcl47$468
Metoprolol Succinate32$420
Ibuprofen20$401
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide28$400
Dicyclomine Hcl13$361
Rosuvastatin Calcium33$329
Escitalopram Oxalate19$326

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$58$4,01611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 979 nurse practitioner providers in Utah.

Other nurse practitioner in Ogden

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →